[ad_1]
Renal denervation market
According to the Renal Denervation Market Report published by Allied Market Research, the global market is valued at $ 197 million in 2015 and $ 3.153 million in 2022, with a compound annual growth rate of 48.5%. It is estimated that the Symplicity Kidney Denervation System will continue to generate the highest revenues for the entire forecast period as the number of product registrations worldwide increases. Europe has taken a leading position in the global market in 2015 and is expected to remain in the vanguard in the future.
Compared to multi-disciplinary therapies, high blood pressure and hypertension, lifestyle changes, improved healthcare infrastructure in developing countries, and increased cost-effectiveness of renal hair loss procedures are driving market growth. However, the inconvenience and suffering suffered by patients during stringent licensing procedures and the procedures for kidney extraction devices hinder the growth of the market.
Download a sample report in PDF format @ www.alliedmarketresearch.com/request-sample/522
The Vessix renal denervation system is expected to grow at its fastest pace, with an average annual growth rate of 57.6% between 2016 and 2022, as it can be used for variable diameter arteries (with expandable balloons of varying sizes). ). It also uses a color graphical user interface to improve the accuracy and operation of the device. Boston Scientific, manufacturer of the renal denervation system Vessix, believes this market represents potential for potential growth for business expansion.
Radio Frequency was the most frequently used technique in the kidney aid market. It was also an important sector in 2015 and is expected to play a leading role throughout the forecast period. The ultrasound should reach a high CAGR of 56.4% as it overcomes the limitations of wireless devices.
Key Findings of the Renal Denervation Market:
• Depending on the type of product, the area of the Symplicity renal denervation system is the largest and the Vessix renal denervation system is expected to grow the fastest.
• The radio frequency sector dominated the entire kidney relief market.
• The ultrasound should grow at a CAGR of 56.4% over the period of badysis.
• Europe was a major geographic market in 2015 and is expected to continue over the next few years.
• The Asia Pacific region is expected to grow at an average annual rate of 50.6%.
Make an inquiry before buying @ www.alliedmarketresearch.com/purchase-enquiry/522
The high share of Europe is due to the rapid start of this technology in European countries. In addition, most devices in this market are CE marked and can be sold in Europe. On the other hand, the North American market occupies a small percentage of the North American market because the kidney removal system is not approved by the FDA and is available for research purposes only. During the period badyzed, Asia-Pacific is expected to experience the fastest growth due to the numerous growth opportunities for unmet medical needs in hypertension treatment and increased awareness of the use of advanced technologies such as kidney failure systems. The prevalence of resistant hypertension was high.
Large companies have embraced product development as a key strategy to meet the changing needs of the industry. The main players in this market are Ablative Solutions, Inc., Boston Scientific Corporation, Cardiosonic Ltd., Kona Medical, Inc., Medtronic plc, Mercator MedSystems, ReCor Medical, Inc., Renal Dynamics Limited, Jude Medical, Inc. and Terumo Medical. Corporation. . Starting in 2015, Medtronic dominated the global renal hernia market, followed by St. Jude Medical.
Access to Summery Full @ www.alliedmarketresearch.com/renal-denervation-devices-ma …
About us:
Allied Market Research, a market research and advisory firm of Allied Analytics LLP, provides market intelligence and market research reports to large and small businesses. The company helps its clients develop business strategies and achieve sustainable growth in their respective fields.
Contact:
David Correa
5933 NE Win Sivers Drive
# 205, Portland, OR 97220
United States
No charge (United States / Canada):
+ 1-800-792-5285, + 1-503-894-6022, + 1-503-446-1141
United Kingdom: + 44-845-528-1300
Hong Kong: + 852-301-84916
India (Pune): + 91-20-66346060
Fax: +1 855-550-5975
This press release was published on openPR.
Source link
